{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:01:14Z","timestamp":1794553274847,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01765-w","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:01:13Z","timestamp":1785920473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice"],"prefix":"10.1038","author":[{"given":"Jingjing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-3894","authenticated-orcid":false,"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4124-2391","authenticated-orcid":false,"given":"Yinghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-5084","authenticated-orcid":false,"given":"Qiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-0728","authenticated-orcid":false,"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-3342","authenticated-orcid":false,"given":"Yingdai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-1369","authenticated-orcid":false,"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-1095","authenticated-orcid":false,"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-9721","authenticated-orcid":false,"given":"Tuo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4281-2392","authenticated-orcid":false,"given":"Shuquan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature25022","volume":"553","author":"E Laurenti","year":"2018","unstructured":"Laurenti, E. & Gottgens, B. From haematopoietic stem cells to complex differentiation landscapes. Nature 553, 418\u2013426 (2018).","journal-title":"Nature"},{"key":"1765_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1182\/blood.2022018071","volume":"142","author":"F Anjos-Afonso","year":"2023","unstructured":"Anjos-Afonso, F. & Bonnet, D. Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level? Blood 142, 509\u2013518 (2023).","journal-title":"Blood"},{"key":"1765_CR3","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1242\/dev.106575","volume":"141","author":"A Nakamura-Ishizu","year":"2014","unstructured":"Nakamura-Ishizu, A., Takizawa, H. & Suda, T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development 141, 4656\u20134666 (2014).","journal-title":"Development"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.stem.2023.04.014","volume":"30","author":"S Ferrari","year":"2023","unstructured":"Ferrari, S. et al. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy. Cell Stem Cell 30, 549\u2013570 (2023).","journal-title":"Cell Stem Cell"},{"key":"1765_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","volume":"21","author":"RA Morgan","year":"2017","unstructured":"Morgan, R. A., Gray, D., Lomova, A. & Kohn, D. B. Hematopoietic stem cell gene therapy: progress and lessons learned. Cell Stem Cell 21, 574\u2013590 (2017).","journal-title":"Cell Stem Cell"},{"key":"1765_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana, M., Bushman, F. D., Miccio, A., Andre-Schmutz, I. & Six, E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat. Rev. Drug Discov. 18, 447\u2013462 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1765_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2021.01.001","volume":"28","author":"CM Drysdale","year":"2021","unstructured":"Drysdale, C. M. et al. Hematopoietic-stem-cell-targeted gene-addition and gene-editing strategies for beta-hemoglobinopathies. Cell Stem Cell 28, 191\u2013208 (2021).","journal-title":"Cell Stem Cell"},{"key":"1765_CR8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","volume":"381","author":"L Xu","year":"2019","unstructured":"Xu, L. et al. CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia. N. Engl. J. Med. 381, 1240\u20131247 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1765_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","volume":"7","author":"KA Everette","year":"2023","unstructured":"Everette, K. A. et al. Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nat. Biomed. Eng. 7, 616\u2013628 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"1765_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2020.12.015","volume":"28","author":"S Rao","year":"2021","unstructured":"Rao, S. et al. Dissecting ELANE neutropenia pathogenicity by human HSC gene editing. Cell Stem Cell 28, 833\u2013845.e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"1765_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari, G., Thrasher, A. J. & Aiuti, A. Gene therapy using haematopoietic stem and progenitor cells. Nat. Rev. Genet. 22, 216\u2013234 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"1765_CR12","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.ymthe.2025.04.029","volume":"33","author":"T John","year":"2025","unstructured":"John, T. & Czechowicz, A. Clinical hematopoietic stem cell-based gene therapy. Mol. Ther. 33, 2663\u20132678 (2025).","journal-title":"Mol. Ther."},{"key":"1765_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","volume":"124","author":"B Gyurkocza","year":"2014","unstructured":"Gyurkocza, B. & Sandmaier, B. M. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 124, 344\u2013353 (2014).","journal-title":"Blood"},{"key":"1765_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/17474086.2016.1268048","volume":"10","author":"CL Ebens","year":"2017","unstructured":"Ebens, C. L., MacMillan, M. L. & Wagner, J. E. Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations. Expert Rev. Hematol. 10, 81\u201397 (2017).","journal-title":"Expert Rev. Hematol."},{"key":"1765_CR15","first-page":"2085","volume":"141","author":"C Li","year":"2023","unstructured":"Li, C. et al. In vivo HSC prime editing rescues sickle cell disease in a mouse model. Blood 141, 2085\u20132099 (2023).","journal-title":"Blood"},{"key":"1765_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI122836","volume":"129","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. J. Clin. Invest. 129, 598\u2013615 (2019).","journal-title":"J. Clin. Invest."},{"key":"1765_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","volume":"29","author":"C Li","year":"2021","unstructured":"Li, C. et al. In vivo HSC gene therapy using a bi-modular HDAd5\/35++ vector cures sickle cell disease in a mouse model. Mol. Ther. 29, 822\u2013837 (2021).","journal-title":"Mol. Ther."},{"key":"1765_CR18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","volume":"5","author":"C Li","year":"2021","unstructured":"Li, C. et al. In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice. Blood Adv. 5, 1122\u20131135 (2021).","journal-title":"Blood Adv."},{"key":"1765_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1765_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17029-3","volume":"11","author":"T Wei","year":"2020","unstructured":"Wei, T., Cheng, Q., Min, Y. L., Olson, E. N. & Siegwart, D. J. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 11, 3232 (2020).","journal-title":"Nat. Commun."},{"key":"1765_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. 19, 1409\u20131417 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1765_CR22","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41587-024-02470-2","volume":"43","author":"H Kim","year":"2025","unstructured":"Kim, H. et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nat. Biotechnol. 43, 1813\u20131820 (2025).","journal-title":"Nat. Biotechnol."},{"key":"1765_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"1765_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211420","volume":"35","author":"K Lam","year":"2023","unstructured":"Lam, K. et al. Optimizing lipid nanoparticles for delivery in primates. Adv. Mater. 35, e2211420 (2023).","journal-title":"Adv. Mater."},{"key":"1765_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"1765_CR26","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi, D., Toyonaga, S. & Anderson, D. G. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 23, 2938\u20132944 (2023).","journal-title":"Nano Lett."},{"key":"1765_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/10428199809057558","volume":"30","author":"L Escribano","year":"1998","unstructured":"Escribano, L., Ocqueteau, M., Almeida, J., Orfao, A. & San Miguel, J. F. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk. Lymphoma 30, 459\u2013466 (1998).","journal-title":"Leuk. Lymphoma"},{"key":"1765_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20131128","volume":"211","author":"JY Shin","year":"2014","unstructured":"Shin, J. Y., Hu, W., Naramura, M. & Park, C. Y. High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J. Exp. Med. 211, 217\u2013231 (2014).","journal-title":"J. Exp. Med."},{"key":"1765_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1126\/science.1242088","volume":"342","author":"DE Bauer","year":"2013","unstructured":"Bauer, D. E. et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342, 253\u2013257 (2013).","journal-title":"Science"},{"key":"1765_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat. Med. 25, 776\u2013783 (2019).","journal-title":"Nat. Med."},{"key":"1765_CR31","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cell.2016.04.048","volume":"165","author":"JC Ulirsch","year":"2016","unstructured":"Ulirsch, J. C. et al. Systematic functional dissection of common genetic variation affecting red blood cell traits. Cell 165, 1530\u20131545 (2016).","journal-title":"Cell"},{"key":"1765_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1765_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res."},{"key":"1765_CR34","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood.2022019333","volume":"142","author":"V Vavassori","year":"2023","unstructured":"Vavassori, V. et al. Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells. Blood 142, 812\u2013826 (2023).","journal-title":"Blood"},{"key":"1765_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","volume":"15","author":"PK Mandal","year":"2014","unstructured":"Mandal, P. K. et al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9. Cell Stem Cell 15, 643\u2013652 (2014).","journal-title":"Cell Stem Cell"},{"key":"1765_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/humu.22308","volume":"34","author":"M Germeshausen","year":"2013","unstructured":"Germeshausen, M. et al. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. Hum. Mutat. 34, 905\u2013914 (2013).","journal-title":"Hum. Mutat."},{"key":"1765_CR37","doi-asserted-by":"publisher","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","volume":"3","author":"J Skokowa","year":"2017","unstructured":"Skokowa, J., Dale, D. C., Touw, I. P., Zeidler, C. & Welte, K. Severe congenital neutropenias. Nat. Rev. Dis. Primers 3, 17032 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1765_CR38","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1182\/blood.2024024599","volume":"144","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. TR4 and BCL11A repress gamma-globin transcription via independent mechanisms. Blood 144, 2762\u20132772 (2024).","journal-title":"Blood"},{"key":"1765_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.stem.2024.10.014","volume":"32","author":"S Demirci","year":"2025","unstructured":"Demirci, S. et al. BCL11A +58\/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody\u2013drug conjugate. Cell Stem Cell 32, 209\u2013226.e8 (2025).","journal-title":"Cell Stem Cell"},{"key":"1765_CR40","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1172\/JCI140189","volume":"130","author":"S Demirci","year":"2020","unstructured":"Demirci, S. et al. BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicity. J. Clin. Invest. 130, 6677\u20136687 (2020).","journal-title":"J. Clin. Invest."},{"key":"1765_CR41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.adp3025","volume":"386","author":"G Zheng","year":"2024","unstructured":"Zheng, G. et al. A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing. Science 386, 1010\u20131018 (2024).","journal-title":"Science"},{"key":"1765_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3324\/haematol.2014.115212","volume":"101","author":"AP Theocharides","year":"2016","unstructured":"Theocharides, A. P., Rongvaux, A., Fritsch, K., Flavell, R. A. & Manz, M. G. Humanized hemato-lymphoid system mice. Haematologica 101, 5\u201319 (2016).","journal-title":"Haematologica"},{"key":"1765_CR43","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41587-022-01278-2","volume":"40","author":"M Hirano","year":"2022","unstructured":"Hirano, M. et al. A highly photostable and bright green fluorescent protein. Nat. Biotechnol. 40, 1132\u20131142 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1765_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ajhg.2021.03.005","volume":"108","author":"X Bao","year":"2021","unstructured":"Bao, X. et al. Epigenetic inactivation of ERF reactivates gamma-globin expression in beta-thalassemia. Am. J. Hum. Genet. 108, 709\u2013721 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"1765_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41551-025-01480-y","volume":"10","author":"S Xu","year":"2026","unstructured":"Xu, S. et al. In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery. Nat. Biomed. Eng. 10, 473\u2013489 (2026).","journal-title":"Nat. Biomed. Eng."},{"key":"1765_CR46","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.3324\/haematol.2019.232959","volume":"105","author":"A Nagamachi","year":"2020","unstructured":"Nagamachi, A., Kikuchi, J., Kanai, A., Furukawa, Y. & Inaba, T. Kinetics of cytokine receptor internalization under steady-state conditions affects growth of neighboring blood cells. Haematologica 105, e325\u2013e327 (2020).","journal-title":"Haematologica"},{"key":"1765_CR47","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.ymthe.2023.08.003","volume":"31","author":"K Berckmueller","year":"2023","unstructured":"Berckmueller, K. et al. CD90-targeted lentiviral vectors for HSC gene therapy. Mol. Ther. 31, 2901\u20132913 (2023).","journal-title":"Mol. Ther."},{"key":"1765_CR48","doi-asserted-by":"publisher","unstructured":"Botchkarev, V. V. Jr et al. In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02915-2 (2025).","DOI":"10.1038\/s41587-025-02915-2"},{"key":"1765_CR49","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/stem.1661","volume":"32","author":"LE Sidney","year":"2014","unstructured":"Sidney, L. E., Branch, M. J., Dunphy, S. E., Dua, H. S. & Hopkinson, A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 32, 1380\u20131389 (2014).","journal-title":"Stem Cells"},{"key":"1765_CR50","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1182\/blood-2002-02-0355","volume":"100","author":"HS Radomska","year":"2002","unstructured":"Radomska, H. S. et al. Transgenic targeting with regulatory elements of the human CD34 gene. Blood 100, 4410\u20134419 (2002).","journal-title":"Blood"},{"key":"1765_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.642198","volume":"12","author":"G Adigbli","year":"2021","unstructured":"Adigbli, G. et al. Development of LT-HSC-reconstituted non-irradiated NBSGW mice for the study of human hematopoiesis in vivo. Front. Immunol. 12, 642198 (2021).","journal-title":"Front. Immunol."},{"key":"1765_CR52","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1182\/blood-2010-11-321414","volume":"118","author":"Z Hu","year":"2011","unstructured":"Hu, Z., Van Rooijen, N. & Yang, Y. G. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 118, 5938\u20135946 (2011).","journal-title":"Blood"},{"key":"1765_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stemcr.2016.08.005","volume":"7","author":"S Rahmig","year":"2016","unstructured":"Rahmig, S. et al. Improved human erythropoiesis and platelet formation in humanized NSGW41 mice. Stem Cell Rep. 7, 591\u2013601 (2016).","journal-title":"Stem Cell Rep."},{"key":"1765_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1607707","volume":"13","author":"X Dai","year":"2025","unstructured":"Dai, X. et al. Preclinical efficacy and safety evaluation of BD211 autologous CD34+ hematopoietic stem cell injection for transfusion-dependent beta-thalassemia in NCG-X mice. Front. Cell Dev. Biol. 13, 1607707 (2025).","journal-title":"Front. Cell Dev. Biol."},{"key":"1765_CR55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","volume":"5","author":"D Conant","year":"2022","unstructured":"Conant, D. et al. Inference of CRISPR edits from Sanger trace data. CRISPR J. 5, 123\u2013130 (2022).","journal-title":"CRISPR J."},{"key":"1765_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"1765_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1765_CR58","unstructured":"Du, J. et al. Bulk RNA-sequencing data for \u2018In vivo engineering of hematopoietic stem cells by targeted lipid nanoparticles within humanized mice\u2019. NCBI GEO https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE318716 (2026)."},{"key":"1765_CR59","unstructured":"Du, J. et al. Raw targeted sequencing datasets for \u2018In vivo engineering of hematopoietic stem cells by targeted lipid nanoparticles within humanized mice\u2019. GSA https:\/\/ngdc.cncb.ac.cn\/gsa-human\/browse\/HRA015967 (2026)."},{"key":"1765_CR60","unstructured":"Du, J. et al. Raw targeted sequencing datasets for \u2018In vivo engineering of hematopoietic stem cells by targeted lipid nanoparticles within humanized mice\u2019. GSA https:\/\/ngdc.cncb.ac.cn\/gsa-human\/browse\/HRA016559 (2026)."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01765-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01765-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:11Z","timestamp":1787162531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01765-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":60,"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01765-w","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}